Bioscience is a top manufacturing technology priority across the federal government and is critical for U.S. competitiveness. While the United States maintains a world leadership position in engineering biology and bioscience technology development, other countries are investing heavily in these areas, putting the United States at risk of losing its competitive advantage. This report explores how to best leverage limited resources in a way that creates the most benefit out of federal investment in research labs and in the marketplace.
